Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03006328 · ClinicalTrials.gov registry record · NA

The GEM (Goals for Eating and Moving) Study

A NA study of Obesity and Weight Gain, sponsored by NYU Langone Health.

Completed
Registry status
NA
Development phase
489
Enrollment target
1
Study location

NCT03006328 is a NA study of Obesity and Weight Gain that has completed, run by NYU Langone Health. The registered enrollment target is 489 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03006328, a NA study of Obesity and Weight Gain, has completed, sponsored by NYU Langone Health.

COMPLETED
Registry status
NA
Development phase
489 participants
Enrollment target
1
Study location

Study Summary

The GEM intervention leverages the patient-centered medical home model by using the GEM tool to provide individually tailored, patient-centered care, promote standardized weight management counseling by health coaches and primary team members, coordinate care between teams and other weight management service providers/programs (e.g., dietitians, health educators, DPP), and provide feedback to the provider and primary care team about patients' weight management-related goals, progress, and care.

Conditions Studied

Interventions

  • BEHAVIORAL Enhanced Usual Care
  • BEHAVIORAL GEM

Study Locations (1)

New York

  • New York University Medical Center Institutional Review Boards - New York

Trial Details

FieldValue
Enrollment Target 489 participants
Start Date 2017-11-20
Est. Completion 2022-02-22
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT03006328

The ClinicalTrials.gov registry entry for NCT03006328 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 489 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (40% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT03006328 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03006328 about?

NCT03006328 is a clinical study titled "The GEM (Goals for Eating and Moving) Study". The GEM intervention leverages the patient-centered medical home model by using the GEM tool to provide individually tailored, patient-centered care, promote standardized weight management counseling by health coaches and primary team members, coordinate care between teams and other weight managemen...

What is the current status of trial NCT03006328?

This trial is currently completed. It is a NA study. The enrollment target is 489 participants. The study started on 2017-11-20. Estimated completion is 2022-02-22.

What conditions does trial NCT03006328 study?

This clinical trial studies the following conditions: Obesity, Weight Gain.

What interventions are being tested in trial NCT03006328?

The interventions under investigation include: Enhanced Usual Care (BEHAVIORAL), GEM (BEHAVIORAL).

Who is sponsoring clinical trial NCT03006328?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03006328 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.